Aurelia Conte

This inventor holds 20 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 9 EPO patents, primarily in Pharmaceutical Chemistry. Top assignee: Hoffmann-La Roche Inc.. Active years: 2009-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aurelia Conte. Retrieved from https://idiyas.com/inventor/aurelia-conte

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20 (Patent Applications = 3)

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 9 (Patent Applications = 10)

Average Co-Inventor Count = 6.4

ph-index = 3

Forward Citations = 42(Granted Patents)

Location History:

Basel, CH (2009 - 2017)
Shanghai, CN (2013 - 2017)

Company Filing History:

20 out of 5,026

Hoffmann-La Roche Inc.

patents

Years Active: 2009-2017

Loading Chart...

Areas of Expertise:

Aryl-quinoline Derivatives

Urea Derivatives

Bicyclicpyridine Derivatives

Azacyclic Compounds

HSL Inhibitors

Piperidine Derivatives

Aza-pyridopyrimidinone Derivatives

Anthranilamide Compounds

Pyridopyrimidinone Derivatives

Heteroaryl Compounds

Benzyl Amide Compounds

Fatty-Acid Binding Protein Inhibitors

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9809599 - Aryl-quinoline derivatives (2017-11-07),

2. 9708340 - Urea derivatives and their use as fatty-acid binding protein (FABP) inhibitors (2017-07-18),

3. 9562052 - Bicyclicpyridine derivatives (2017-02-07),

4. 9278918 - Urea derivatives and their use as fatty-acid binding protein (FABP) inhibitors (2016-03-08),

5. 9199938 - Aryl-quinoline derivatives (2015-12-01),

6. 8552024 - Azacyclic compounds (2013-10-08),

7. 8501768 - Hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds (2013-08-06),

8. 8497288 - Hexahydropyrroloimidazolone compounds (2013-07-30),

9. 8470843 - Azacyclic compounds (2013-06-25),

10. 8440710 - HSL inhibitors useful in the treatment of diabetes (2013-05-14),

11. 8399676 - Piperidine derivatives (2013-03-19),

12. 8389539 - Azacyclic derivatives (2013-03-05),

13. 8329904 - Azacyclic derivatives (2012-12-11),

14. 8258158 - HSL inhibitors useful in the treatment of diabetes (2012-09-04),

15. 8097634 - Azacyclic derivatives (2012-01-17),

Title: The Trailblazing Journey of Aurelia Conte: A Pioneer in Inventions

Introduction: Aurelia Conte, a visionary inventor based in Basel, Switzerland, has illuminated the realm of innovation with her remarkable contributions. With a portfolio boasting 20 patents, her groundbreaking work has redefined the landscape of technology and healthcare.

Latest Patents: Aurelia's latest patents showcase her expertise in developing novel compounds with profound therapeutic potential. Her inventions include aryl-quinoline derivatives and urea derivatives, which serve as potent inhibitors of fatty-acid binding proteins (FABPs). These compounds hold promise in treating a spectrum of conditions, ranging from metabolic disorders to chronic inflammatory diseases.

Career Highlights: Throughout her illustrious career, Aurelia Conte has been associated with renowned companies such as Hoffmann-La Roche Inc. Her tenure at these esteemed organizations has provided her with the platform to drive innovation and spearhead transformative research in the field of biopharmaceuticals.

Collaborations: Collaborating with visionaries like Werner Neidhart and Holger Kuehne, Aurelia has synergized her inventive prowess to achieve groundbreaking results. The collective efforts of these innovative minds have catalyzed advancements in drug development and therapeutics, revolutionizing the healthcare industry.

Conclusion: In conclusion, Aurelia Conte stands as a beacon of innovation and a testament to the power of perseverance in the face of challenges. Her prolific career, marked by groundbreaking inventions and transformative patents, underscores her unwavering commitment to shaping a better future. Aurelia's ingenuity continues to inspire generations of inventors, propelling the frontiers of technology and healthcare towards new horizons.

Profile summary based on public USPTO records.